1
|
Roder C, Nayak NR, Khan N, Tatagiba M, Inoue I, Krischek B. Genetics of Moyamoya disease. J Hum Genet 2010; 55:711-6. [PMID: 20739943 DOI: 10.1038/jhg.2010.103] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Moyamoya disease (MMD) is a disease pattern consisting of bilateral stenosis of the intracranial internal carotid arteries (ICA) accompanied by a network of abnormal collateral vessels that bypass the stenosis. Once symptomatic, insufficient cerebral blood flow or rupture of the fragile collaterals may cause stroke or hemorrhage, resulting in severe neurological dysfunction or death. The etiology of MMD is still unknown, although few associations with other diseases and environmental factors have been described. Strong regional differences in epidemiological data, as well as known familial cases, turned the focus to genetics for the insight into the disease's pathogenesis. Thus far, several reports have suggested specific genetic loci and individual genes as predisposing to MMD, but none have demonstrated reproducible results in independent cohorts. Small sample sizes, as well as a likely multifactorial origin, seem to be the most challenging tasks in identifying the disease-causing mechanisms. Once identified, susceptibility genes may allow preventive screening and a possible development of novel therapeutic options.
Collapse
Affiliation(s)
- Constantin Roder
- Department of Neurosurgery, University of Tübingen, Tübingen, Germany
| | | | | | | | | | | |
Collapse
|
2
|
Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, Marks MP, Steinberg GK. Clinical outcome after 450 revascularization procedures for moyamoya disease. J Neurosurg 2009; 111:927-35. [PMID: 19463046 DOI: 10.3171/2009.4.jns081649] [Citation(s) in RCA: 310] [Impact Index Per Article: 20.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Object
Moyamoya disease (MMD) is a rare cerebrovascular disease mainly described in the Asian literature. To address a lack of data on clinical characteristics and long-term outcomes in the treatment of MMD in North America, the authors analyzed their experience at Stanford University Medical Center. They report on a consecutive series of patients treated for MMD and detail their demographics, clinical characteristics, and long-term surgical outcomes.
Methods
Data obtained in consecutive series of 329 patients with MMD treated microsurgically by the senior author (G.K.S.) between 1991 and 2008 were analyzed. Demographic, clinical, and surgical data were prospectively gathered and neurological outcomes assessed in postoperative follow-up using the modified Rankin Scale. Association of demographic, clinical, and surgical data with postoperative outcome was assessed by chi-square, uni- and multivariate logistic regression, and Kaplan-Meier survival analyses.
Results
The authors treated a total of 233 adult patients undergoing 389 procedures (mean age 39.5 years) and 96 pediatric patients undergoing 168 procedures (mean age 10.1 years). Direct revascularization technique was used in 95.1% of adults and 76.2% of pediatric patients. In 264 patients undergoing 450 procedures (mean follow-up 4.9 years), the surgical morbidity rate was 3.5% and the mortality rate was 0.7% per treated hemisphere. The cumulative 5-year risk of perioperative or subsequent stroke or death was 5.5%. Of the 171 patients presenting with a transient ischemic attack, 91.8% were free of transient ischemic attacks at 1 year or later. Overall, there was a significant improvement in quality of life in the cohort as measured using the modified Rankin Scale (p < 0.0001).
Conclusions
Revascularization surgery in patients with MMD carries a low risk, is effective at preventing future ischemic events, and improves quality of life. Patients in whom symptomatic MMD is diagnosed should be offered revascularization surgery.
Collapse
Affiliation(s)
- Raphael Guzman
- 1Departments of Neurosurgery and
- 3Stanford Stroke Center, Stanford University School of Medicine, Stanford, California
| | - Marco Lee
- 1Departments of Neurosurgery and
- 3Stanford Stroke Center, Stanford University School of Medicine, Stanford, California
| | - Achal Achrol
- 1Departments of Neurosurgery and
- 3Stanford Stroke Center, Stanford University School of Medicine, Stanford, California
| | - Teresa Bell-Stephens
- 1Departments of Neurosurgery and
- 3Stanford Stroke Center, Stanford University School of Medicine, Stanford, California
| | - Michael Kelly
- 1Departments of Neurosurgery and
- 3Stanford Stroke Center, Stanford University School of Medicine, Stanford, California
| | - Huy M. Do
- 1Departments of Neurosurgery and
- 2Radiology, and
- 3Stanford Stroke Center, Stanford University School of Medicine, Stanford, California
| | - Michael P. Marks
- 1Departments of Neurosurgery and
- 2Radiology, and
- 3Stanford Stroke Center, Stanford University School of Medicine, Stanford, California
| | - Gary K. Steinberg
- 1Departments of Neurosurgery and
- 3Stanford Stroke Center, Stanford University School of Medicine, Stanford, California
| |
Collapse
|